Document:

<PAGE>
                                                                    EXHIBIT 4.1

THE SECURITY EVIDENCED BY THIS NOTE AND THE SECURITIES ISSUABLE UPON CONVERSION
OF THIS NOTE HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS
AMENDED, AND MAY NOT BE SOLD, TRANSFERRED OR ASSIGNED UNLESS THERE IS AN
EFFECTIVE REGISTRATION STATEMENT UNDER SUCH ACT COVERING SUCH SECURITIES, THE
SALE, TRANSFER OR ASSIGNMENT IS MADE IN ACCORDANCE WITH RULE 144 UNDER THE ACT,
OR THE BORROWER RECEIVES AN OPINION OF COUNSEL FOR THE HOLDER OF THESE
SECURITIES REASONABLY SATISFACTORY TO THE BORROWER, STATING THAT SUCH SALE,
TRANSFER OR ASSIGNMENT IS EXEMPT FROM THE REGISTRATION AND PROSPECTUS DELIVERY
REQUIREMENTS OF SUCH ACT.

                             SECURED PROMISSORY NOTE

Up to Six Million Dollars

($6,000,000)                                                   November 29, 2001

        FOR VALUE RECEIVED, the undersigned, Euphonix, Inc., a California
corporation ("Borrower"), hereby promises to pay to Dieter Meier ("Meier"),
Walter Bosch ("Bosch") and to any other persons or entities listed on Exhibit A
hereto from time to time (individually, an "Investor" and, collectively, the
"Investors"), or registered assigns, their pro rata portion (the "Pro Rata
Share") of the aggregate amount of all Advances (as defined in Section A.2
hereof) made by the Investors set forth on Exhibit A, up to the principal amount
of Six Million Dollars ($6,000,000) (the "Maximum Principal Amount"), together
with the accrued interest thereon as provided herein.

A.      Principal.

        1. Commitments. Subject to the terms and conditions of this Secured
Promissory Note (this "Note"), Meier and Bosch agree to loan the Maximum
Principal Amount to Borrower and are jointly and severally liable for the
Maximum Principal Amount. In the event that any persons or entities (other than
Meier and Bosch) within 14 calendar days of the date of this Note, signs a
counterpart signature page, substantially in the form of Schedule 1 hereto, to
make Advances (as defined in Section A.2 hereof) to Borrower in an aggregate
amount of not less than $250,000, such persons or entities shall be added as
Investors hereunder, and the commitment by Meier and Bosch shall be reduced pro
rata by the amount of the Advances the new Investors have agreed to make. Such
new Investors may elect to make Advances under this Note in an amount up to
their pro rata share of the principal outstanding on all of Borrower's
outstanding secured promissory notes, or in excess of such amount upon the
written approval of Meier, Bosch and Borrower. In the event that the Investors
wish to make Advances that, in the aggregate and including the initial Advances
described in Section A.3 hereof, would be greater than the Maximum Principal
Amount, then the dollar amount of the Advances by each Investor shall be reduced
on a pro rata basis. Each Investor's pro rata share is equal to a fraction, (a)
the numerator of which is the dollar amount of all of such

<PAGE>

Investor's investments in Borrower, and (b) the denominator of which is the
dollar amount of the investments by all Investors who wish to make Advances
under this Note.

        2. Advances. From the date hereof until 5:00 p.m. Pacific time on June
30, 2003, Borrower may from time to time request advances from the Investors
(individually an "Advance" and collectively, the "Advances") by giving written
notice to the Investors in accordance with the terms hereof, which notice shall
indicate the amount of the Advance requested; provided, however, that the
Advance requested shall be in increments of at least $100,000, shall not exceed
$500,000 per month and shall be limited to three (3) requests per month.
Borrower is not obligated to request an Advance in any calendar month. Subject
to the satisfaction or waiver of the conditions set forth in Section A.4 below,
and provided that the requested Advance would not cause an Event of Default (as
defined in Section E below) to occur and otherwise complies with the terms
hereof, the Investors shall make their pro rata share of the Advance to Borrower
within three (3) business days of receipt of Borrower's notice of request. The
Investors shall not be obligated to make any Advance to the extent that such
Advance, when aggregated with all prior Advances, would exceed the Maximum
Principal Amount. As soon as practicable after receipt of an Advance, Borrower
shall set forth on Exhibit A opposite the name of the Investor the amount of the
Advance and the date received.

        3. Initial Advances. Borrower acknowledges that Messrs. Meier and Bosch
have previously advanced a total of $1,000,000 to Borrower, $850,000 by Meier
and $150,000 by Bosch, in reliance upon the finalization of the terms of this
Note, which advances shall constitute the initial Advances under this Note,
deemed received as of the date hereof, and shall be so reflected by Borrower on
Exhibit A.

        4. Conditions to Advances. Borrower's right to request, and the
Investors' obligation to make, each Advance shall be subject, in each case, to
the satisfaction of the following conditions, any or all of which may be waived
by the Investor(s) making such Advance or by the holders of a majority of the
outstanding principal amount of this Note, in their sole and exclusive
discretion, to the extent permitted by law and subject to Section H.6:

            (a) The representations and warranties contained in Section D.2 and
Section D.3 shall be true and correct in all material respects on and as of the
date of the request for an Advance and on the effective date of each Advance as
though made at and as of each such date, and no Event of Default shall have
occurred and be continuing, or would result from such Advance.

            (b) There shall be no law, order, rule or regulation of any
governmental authority in effect which has the effect of prohibiting, making
unlawful or hindering any of the transactions contemplated by this Note.

            (c) There shall be no outstanding Event of Default and the Chief
Executive Officer and another executive officer shall certify that no condition
exists that, with notice or passage of time or both, would reasonably be
expected to constitute an Event of Default.

            (d) The Board of Directors of Borrower shall have approved this Note
and all transactions evidence by this Note, including without limitation the
conversion feature of this Note.

                                      -2-
<PAGE>

            (e) There shall be no Liens (as defined herein) on the Collateral
(as defined herein) that are senior to the Lien held by the Investors, except
Permitted Liens.

            (f) Borrower shall deliver a certificate signed on behalf of
Borrower by the Chief Executive Officer and another executive officer certifying
as to Borrower's compliance with all of the above conditions (unless any of such
conditions is waived in writing by the Investors).

        5. Use of Proceeds. The proceeds of the Advances shall be used for
general corporate purposes, including working capital and expenses incurred in
the ordinary course of Borrower's business, and shall not be used for payments
or distributions to shareholders, directors, officers, employees, consultants or
affiliates of Borrower; provided, however, such proceeds may be used for the
payment of compensation to any director, officer, employee and consultant of
Borrower if such compensation is (a) per an agreement with the Borrower in
existence prior to September 1, 2001, (b) approved by the Borrower's Board of
Directors, or (c) not in excess of $75,000 per year.

B. Interest. Interest shall accrue with respect to Advances on the principal sum
hereunder at the per annum rate of ten percent (10.00%), net of any applicable
deductions or withholding taxes. Interest payable hereunder shall be calculated
on the basis of a three hundred sixty five (365) day year for actual days
elapsed. Interest shall be due and payable (unless converted as set forth in
Section C below) upon payment or conversion of the principal sum of this Note
pursuant to Section C below. Notwithstanding anything herein to the contrary,
interest shall accrue with respect to Advances on the principal sum hereunder at
the per annum rate of eighteen percent (18.00%), net of any applicable
deductions or withholding taxes, (i) during any period for which an Event of
Default shall have occurred and be continuing or (ii) any time after the
Maturity Date if and only if all Advances and the interest thereon have neither
been paid in full nor converted in full into Common Stock (as defined herein)
pursuant to Section C herein.

C. Payment or Conversion.

        1. Scheduled Payment. Subject to other provisions of this Note, the then
outstanding principal sum of this Note, together with the accrued interest
thereon, shall be due and payable to the Investors on June 30, 2003 (the
"Maturity Date"), each Investor to receive his, her or its Pro Rata Share.

        2. Prepayment. Borrower shall not have the right to prepay, in whole or
in part, the outstanding principal sum of this Note without the written consent
of the holders of a majority of the outstanding principal amount of this Note.

        3. Form of Payment. Unless converted pursuant to the terms set forth
below, the outstanding principal sum and accrued interest thereon are to be paid
in lawful money of the United States of America in federal or other immediately
available funds.

        4. Acceleration of Maturity Date.

            (a) Unless waived by the holders of a majority of the outstanding
principal amount of this Note, the outstanding principal sum from all Advances
as of the date thereof and accrued interest thereon, shall accelerate and become
due and payable in full, according to the

                                      -3-
<PAGE>

Investor's Pro Rata Share, upon (i) a Change in Control (as defined below), or
(ii) January 31, 2002, in the event that all necessary regulatory approvals and
consents and the approval by the holders of a majority of the Common Stock
(defined in Section C.5(a) below) are not obtained by that date, provided,
however, that this clause (ii) shall not apply and the outstanding principal and
interest shall not become due or payable if (x) shareholder approval is not
obtained as a result of the Investors failing to so vote or consent or (y) the
Articles of Incorporation are amended to authorize at least 150 million shares
of Common Stock.

            (b) "Change of Control" means the occurrence (any such occurrence, a
"Change of Control Event") of: (i) the sale, transfer or other disposition of
any of Borrower's material assets (not including product inventory for sale to
customers in the ordinary course of business); (ii) the acquisition of voting
control in excess of 50% of Borrower by persons (other than the Investors); or
(iii) the merger or consolidation of Borrower with or into another entity
whereby the holders of Borrower's voting securities prior to such merger or
consolidation hold less than 50% of the voting securities of the surviving
entity. Notice of any such Change of Control Event shall be provided to the
Investors fourteen (14) calendar days prior to the consummation of any such
Change of Control Event (the date of such consummation, the "Consummation
Date").

            (c) Notwithstanding Section C.4(a) above, upon a Change of Control
Event, each Investor shall have the election (the "Liquidation Election"), in
lieu of the acceleration of payment of his Advances and accrued interest thereon
as described in Section C.4(a) above, to receive upon the Consummation Date the
same consideration to be received by any holder of an issued and outstanding
share of Common Stock, as if such Investor had converted at the Conversion Price
the principal amount of all of his Advances, together with accrued interest
thereon, into shares of Common Stock immediately prior to the Consummation Date.
An Investor must provide notice to Borrower of his Liquidation Election at least
five (5) calendar days prior to the Consummation Date.

        5. Conversion.

            (a) Upon obtaining all necessary regulatory approvals and the
approval by holders of a majority of the shares of common stock of Borrower (the
"Common Stock") of an amendment to the Company's Articles of Incorporation to
authorize a sufficient number of additional shares of Common Stock for potential
issuance upon conversion of the Warrant Shares (as defined below) and this Note
("Shareholder Approval"), the outstanding principal from all of the Advances,
together with accrued interest thereon, shall be convertible at the option of
each of the Investors into shares of Common Stock; provided, however, that the
Investors must provide at least ten (10) days prior written notice to Borrower
prior to such conversion. The number of shares of Common Stock to be issued upon
such conversion to each Investor shall be equal to the quotient obtained by
dividing the amount of each Advance made by such Investor plus accrued interest
thereon by the Conversion Price, rounded up to the nearest whole share. The
"Conversion Price" shall equal the lower of: (i) $0.35 per share or (ii) the
average of the closing price per share of the Common Stock during the five
trading days immediately preceding the date that such Advance is received by the
Borrower; provided, however, that the Conversion Price cannot be less than $0.02
per share. The Conversion Price relating to each Advance shall be set forth on
Exhibit A.

                                      -4-
<PAGE>

            (b) At its expense, Borrower will, as soon as practicable
thereafter, issue and deliver to each Investor, at its principal office, or
other address notified by each Investor to Borrower from time to time, a
certificate or certificates for the number of shares to which the Investor is
entitled upon such conversion. Upon such conversion of this Note, Borrower will
be forever released from all of its obligations and liabilities under this Note,
to the extent of the conversion. Such conversion may be exercised individually
by each Investor but notwithstanding anything herein to the contrary, each such
conversion must be for the full amount of the outstanding principal and accrued
interest thereon payable to the Investor exercising its rights under Section C.5
hereunder at the time of such exercise.

            (c) Notwithstanding anything to the contrary herein, the Investors
acknowledge that: (i) Borrower will authorize, in its Articles of Incorporation,
a total of 150 million shares of Common Stock, of which 125 million will be
reserved for issuance upon: (x) conversion of this Note, (y) conversion of the
convertible promissory notes dated February 22, 2000, April 14, 2000, September
7, 2000, December 29, 2000 and March 15, 2001, and (z) exercise of warrants
issued pursuant to Section G.1 of this Note; and that (ii) the Investors cannot
effect any such conversion or exercise as described in clause (i) that exceeds
125 million shares unless and until the shareholders approve an amendment to the
Articles of Incorporation increasing the number of authorized shares to an
amount that permits such exercise or conversion.

            (d) Borrower hereby covenants that it will hold a meeting of its
shareholders, or otherwise seek written consents of its shareholders, as soon as
practicable after the date hereof in order to seek all necessary shareholder
approvals for the transactions contemplated by this Note.

D.      Security Interest.

        1. Grant of Security Interest. Effective as of the date hereof, Borrower
grants to the Investors a security interest in Borrower's right, title and
interest in and to the Collateral (as defined herein) to secure the payment of
all of the outstanding indebtedness hereunder (the "Secured Obligations")
including, without limitation, principal, accrued interest, other advances made
under this Note and any attorneys' fees to which the Investors are entitled
under this Note.

        2. Representations and Warranties Regarding Collateral. Except as set
forth in the schedule of exceptions delivered in connection herewith (the
"Schedule of Exceptions"), on the date of this Note and as of the date of each
Advance under this Note, Borrower does and shall represent and warrant to the
Investors, that as of each such date:

            (a) Borrower is the true and lawful owner of the Collateral, having
good and marketable title thereto, free and clear of any and all Liens (as
defined in Section H.1) other than the Lien and security interest granted to the
Investors hereunder and Permitted Liens (as defined in Section H.1).

            (b) The lien against the Collateral granted hereunder is and shall
be a first-priority lien against the Collateral and each portion thereof,
subject to Permitted Liens.

                                      -5-
<PAGE>

            (c) Borrower shall not create or assume or permit to exist any such
Lien on or against any of the Collateral except as created or permitted by this
Note and Permitted Liens, and Borrower shall promptly notify the Investors of
any such other Lien against the Collateral and shall defend the Collateral
against, and take all such action as may be reasonably necessary to remove or
discharge, any such Lien.

            (d) Borrower shall take all commercially reasonable actions
necessary to protect and preserve the Collateral which is used in its business
in good condition and repair, subject to ordinary wear and tear, and to preserve
its value and usefulness.

            (e) No part of the Intellectual Property Collateral (as defined in
Section H.1) has been judged invalid or unenforceable, in whole or in part.

            (f) No claim has been made that any part of the Intellectual
Property Collateral violates the rights of any third party.

            (g) The Collateral consists of all assets which are required for the
conduct and operation of the business of Borrower as of the date of this Note.

            (h) The Intellectual Property Collateral includes all of the
technology, know-how and proprietary information which are required for the
conduct and operation of the business of Borrower as of the date of this Note.

        3. General Representations and Warranties. Except as set forth in the
Schedule of Exceptions, on the date of this Note and as of the date of each
Advance under this Note, Borrower does and shall represent and warrant to the
Investors, that as of each such date:

            (a) Organization and Qualification. Borrower is a corporation duly
organized, validly existing and in good standing under the laws of the State of
California. Borrower has the requisite corporate power and authority to own,
operate or lease its properties and to carry on its business as it is now being
conducted and is duly qualified or licensed to do business, and is in good
standing, in each jurisdiction in which the nature of its business or the
properties owned, operated or leased by it makes such qualification, licensing
or good standing necessary, except where the failure to have such power or
authority, or the failure to be so qualified, licensed or in good standing,
would not have a Material Adverse Effect. The term "Material Adverse Effect," as
used in this Note, means any change in or effect (or any development that is
reasonably likely to result in any change or effect) on the business or
financial condition of Borrower that is materially adverse to Borrower taken as
a whole.

            (b) Authority Relative to this Note. This Note has been duly and
validly authorized, executed and delivered by Borrower and constitutes a valid
and binding obligation of Borrower enforceable against Borrower in accordance
with its terms, except that such enforceability (i) may be limited by
bankruptcy, insolvency, moratorium or other similar laws affecting or relating
to the enforcement of creditors' rights generally, (ii) is subject to general
principles of equity, and (iii) is subject to Shareholder Approval.

                                      -6-
<PAGE>

            (c) No Conflict. Except for Shareholder Approval, and execution of
amendments to the Company's existing secured promissory notes by all parties to
such agreements, none of the execution and delivery of this Note by Borrower,
the consummation by Borrower of the transactions contemplated hereby or
compliance by Borrower with any of the provisions hereof will (i) conflict with
or violate the articles of incorporation or by-laws of Borrower, (ii) conflict
with or violate any material statute, ordinance, rule, regulation, order,
judgment or decree applicable to Borrower, or by which Borrower or its
properties or assets may be bound, or (iii) result in a violation or breach of
or constitute a default (or an event which with notice or lapse of time or both
would become a default) under, or give to others any rights of termination,
amendment, acceleration or cancellation of, or result in any loss of any
material benefit, or the creation of any lien on any of the property or assets
of Borrower pursuant to any material agreement, a copy of which would be
required to be filed as an exhibit to the Borrower's Form 10-K or Form 10-Q
filed with the Securities and Exchange Commission (the "Commission") pursuant to
the Securities Exchange Act of 1934, as amended (the "Exchange Act").

            (d) Consents. None of the execution and delivery of this Note by
Borrower, the consummation by Borrower of the transactions contemplated hereby
or compliance by Borrower with any of the provisions hereof will require any
consent, waiver, approval, authorization or permit of, or registration or filing
with or notification to (any of the foregoing being a "Consent"), any government
or subdivision thereof, or any administrative, governmental or regulatory
authority, agency, commission, tribunal or body, domestic, foreign or
supranational (a "Governmental Entity"), except for Consents the failure of
which to obtain or make would not have a Material Adverse Effect or adversely
affect the ability of Borrower to consummate the transactions contemplated
hereby, except qualification (or taking such action as may be necessary to
secure an exemption from qualification, if available) of the offer and sale of
this Note (and the equity securities issuable upon conversion of the Advances)
under applicable federal and state securities laws.

            (e) Material Adverse Change. Since the date of the latest financial
statements filed by Borrower with the Commission prior to the date of this Note,
there has not been any event, occurrence or development that has resulted or, to
the Borrower's knowledge, is reasonably likely to result, in a Material Adverse
Effect.

            (f) Legal Proceedings. There are no legal proceedings (including,
without limitation, any proceedings by or before any governmental or regulatory
authority or agency, or any arbitration proceedings) now pending or, to the best
knowledge of Borrower, threatened, against Borrower, which, if adversely
determined, could have a Material Adverse Effect.

            (g) Skywalker Agreement. The Company is not in breach of the
Purchase Agreement, dated as of April 26, 2000, by and between the Company and
Skywalker Sound, a division of Lucas Digital Ltd. LLC ("Skywalker"), as modified
by the Agreement and Release of Claims, dated as of November 15, 2001, by and
between the Company and Skywalker.

        4. Perfection of Security Interest. Borrower agrees to take all actions
required or requested by the Investors and reasonably necessary to perfect, to
continue the perfection of, and to otherwise give notice of, the Lien granted
hereunder, including, but not limited to, execution and

                                      -7-
<PAGE>

filing of financing statements and the filing of notices of security interests
with the United States Patent and Trademark Office.

E.      Events of Default.

        1. Definition of Event of Default. The occurrence of any one or more of
the following events shall constitute an "Event of Default" hereunder:

            (a) Borrower's material breach of any obligation under this Note or
any of the covenants contained in this Note which material breach is not cured
within 30 days from the notice of the occurrence thereof delivered by the
Investors to Borrower.

            (b) The lapse of 60 days following the institution of proceedings
against Borrower, or Borrower's filing of a petition or answer or consent
seeking reorganization or release, under the federal Bankruptcy Code, or any
other applicable federal or state law relating to creditor rights and remedies,
or Borrower's consent to the filing of any such petition or the appointment of a
receiver, liquidator, assignee, trustee or other similar official of Borrower or
of any substantial part of its property, or Borrower's making of an assignment
for the benefit of creditors, or the taking of corporate action in furtherance
of such action.

            (c) Borrower's adoption of any plan of liquidation, dissolution or
winding up.

            (d) Borrower's material breach of any representation or warranty of
the Borrower made in this Note which material breach is not cured within 30 days
from the notice of the occurrence thereof delivered by the Investors to
Borrower.

        2. Rights and Remedies on Event of Default. The Investors shall have the
following rights and remedies during the continuance of an Event of Default.

            (a) During the continuance of an Event of Default, each of the
Investors shall have the right, themselves or through any of their agents, with
notice to Borrower (as provided below), with respect to any or all of the
Collateral, by any available judicial procedure, or without judicial process
(provided, however, that it is in compliance with the UCC), to declare all
obligations evidenced by this Note immediately due and payable, cease advancing
money or extending credit to or for the benefit of Borrower under this Note, and
to exercise any and all rights afforded to a secured party under the UCC or
other applicable law. Without limiting the generality of the foregoing, each of
the Investors shall have the right to sell or otherwise dispose of all or any
part of the Collateral, either at public or private sale, in lots or in bulk,
for cash or for credit, with or without warranties or representations, and upon
such terms and conditions, all as the Investors, in their reasonable discretion,
may deem advisable, and any Investor shall have the right to purchase at any
such sale. Borrower agrees that a notice sent at least fifteen (15) days before
the time of any intended public sale or of the time after which any private sale
or other disposition of the Collateral is to be made shall be reasonable notice
of such sale or other disposition. The proceeds of any such sale, or other
Collateral disposition shall be applied, first to the expenses of retaking,
holding, storing, processing and preparing for sale, selling, and the like, and
to the Investors' reasonable attorneys' fees and legal expenses, and then to the
Secured Obligations and to the payment of any

                                      -8-
<PAGE>

other amounts required by applicable law, after which the Investors shall
account to Borrower for any surplus proceeds. If, upon the sale or other
disposition of the Collateral, the proceeds thereof are insufficient to pay all
amounts to which the Investors are legally entitled, Borrower shall be liable
for the deficiency, together with interest thereon, and the reasonable fees of
any attorneys the Investors employ to collect such deficiency; provided, however
that the foregoing shall not be deemed to require the Investors to resort to or
initiate proceedings against the Collateral prior to the collection of any such
deficiency or other amount directly from Borrower.

            (b) Borrower appoints all Investors, and any of their respective
officers, employees or agents, with full power of substitution, as Borrower's
true and lawful attorney-in-fact, effective as of the date hereof, with power,
in their own name or in the name of Borrower, during the continuance of an Event
of Default; (i) to endorse any notes, checks, drafts, money orders, or other
instruments of payment in respect of the Collateral that may come into the
Investors' possession; (ii) to sign and endorse any drafts against debtors,
assignments, verifications and notices in connection with accounts, and other
documents relating to Collateral; (iii) to pay or discharge taxes or Liens at
any time levied or placed on or threatened against the Collateral; (iv) to
demand, (v) collect, issue receipt for, compromise, settle and sue for monies
due in respect of the Collateral; (vi) to notify persons and entities obligated
with respect to the Collateral to make payments directly to the Investors; and,
(vii) generally, to do, at the Investors' option and at Borrower's expense, at
any time, or from time to time, all acts and things which the Investors
reasonably deem necessary to protect, preserve and realize upon the Collateral
and the Investors' security interest therein to effect the intent of this Note,
all as fully and effectually as Borrower might or could do; and Borrower hereby
ratifies all that said attorneys shall lawfully do or cause to be done by virtue
hereof. This power of attorney shall be irrevocable as long as any of the
Secured Obligations are outstanding.

            (c) All of the Investors' rights and remedies with respect to the
Collateral, whether established hereby or by any other agreements, instruments
or documents or by law shall be cumulative and may be exercised singly or
concurrently.

            (d) The rights of the Investors under this Note with respect to any
Collateral and the enforcement of the security interests and associated rights
hereunder may be exercised jointly by all Investors or singly by any Investor
representing a majority of the then outstanding principal sum of this Note.

            (e) Except as set forth in Section E.2(d) above, any Investor may
bring suit against Borrower to enforce the provisions of this Note, including
any suit against Borrower to collect amounts due such Investor under this Note.

F. Restrictions on Transfer and Compliance with Securities Act; Investor
Representations and Warranties.

        1. Certificates. Certificates representing any of the shares of Common
Stock acquired pursuant to the provisions of this Note shall have endorsed
thereon the following legends, as appropriate.

                                      -9-
<PAGE>

            (a) Such shares of Common Stock will not be registered under the
Securities Act of 1933, as amended (the "Securities Act"), nor qualified (if
necessary) under applicable state securities laws and consequently will have the
following legend:

        "THE SECURITIES EVIDENCED BY THIS CERTIFICATE HAVE NOT BEEN REGISTERED
        UNDER THE SECURITIES ACT OF 1933, AS AMENDED, AND MAY NOT BE SOLD,
        TRANSFERRED, ASSIGNED OR HYPOTHECATED UNLESS THERE IS AN EFFECTIVE
        REGISTRATION STATEMENT UNDER SUCH ACT COVERING SUCH SECURITIES, THE SALE
        IS MADE IN ACCORDANCE WITH RULE 144 UNDER THE ACT, OR THE COMPANY
        RECEIVES AN OPINION OF COUNSEL FOR THE HOLDER OF THESE SECURITIES
        REASONABLY SATISFACTORY TO THE COMPANY, STATING THAT SUCH SALE,
        TRANSFER, ASSIGNMENT OR HYPOTHECATION IS EXEMPT FROM THE REGISTRATION
        AND PROSPECTUS DELIVERY REQUIREMENTS OF SUCH ACT."

            (b) Any legend required to be placed thereon by any applicable state
securities laws.

            (c) Each Investor, by acceptance hereof or by making any Advances
hereunder, agrees that this Note and the shares of Common Stock to be issued
upon conversion pursuant to the terms hereof are being acquired solely for his
own account and not as a nominee for any other party and not with a view toward
the resale or distribution thereof and that he will not offer, sell or otherwise
dispose of this Note or any shares of Common Stock to be issued upon conversion
pursuant to the terms hereof except under circumstances which will not result in
a violation of the Securities Act or of applicable state securities laws.

            (d) Each Investor, by acceptance hereof, represents that such
Investor is (i) an accredited investor within the meaning of Rule 501 under the
Securities Act and has such knowledge and experience in financial and business
matters that he is capable of evaluating the merits and risks of the purchase of
this Note and can bear the economic risk of his investment; (ii) aware of the
Borrower's business affairs and financial condition; and (iii) aware that this
Note has not been registered under the Securities Act in reliance upon a
specific exemption therefrom.

            (e) Subject to the preceding, this Note may be transferred only upon
surrender of the original Note for registration of transfer, duly endorsed, or
accompanied by a duly executed written instrument of transfer in form
satisfactory to Borrower. Thereupon, a new Note for like principal amount and
interest will be issued to, and registered in the name of, the transferee.
Interest and principal are payable only to the Investors or their transferees
set forth on Exhibit A.

G.      Covenants.

        1. Warrants. Borrower shall issue to the Investors pro rata warrants to
purchase a maximum of 2,571,428 shares of Borrower's Common Stock (the "Warrant
Shares") at an exercise price of $0.01 per share, in the form set forth on
Exhibit B hereto, as follows: (i) on the date hereof, Borrower shall issue to
Meier and Bosch warrants to purchase a total of 642,857 shares, representing

                                      -10-
<PAGE>

25% of the Warrant Shares; (ii) on the date hereof, Borrower shall issue to
Meier and Bosch warrants to purchase a total of 321,428 shares, in consideration
of the Initial Advances; and (iii) Borrower shall issue to each Investor, at the
time an Advance is made by such Investor, a warrant to purchase the number of
shares of Common Stock pursuant to the following formula:

                  N   =         A         x     1,928,571
                           -----------
                           6,000,000

                  where:

                  A = amount of each Advance

                  N = number of shares of Common Stock purchasable

        2. Negative Covenants. So long as any principal amount of this Note
remains outstanding, Borrower shall not, without the consent of the holders of a
majority of the outstanding principal amount of this Note: (i) except as
contemplated by this Note, amend its Articles of Incorporation or Bylaws in any
manner adverse to the Investors, (ii) effect any liquidation, dissolution or
winding up of Borrower, (iii) effect any Change of Control Event, (iv) create or
assume any indebtedness for borrowed money that is pari passu (except for the
Secured Promissory Notes issued by the Company that are outstanding as of the
date hereof) or senior in right of payment to this Note, (except for equipment
financing arrangements secured solely by the equipment purchased), (v) pay any
dividends or other distributions on the capital stock of Borrower, or (vi)
repurchase or redeem any capital stock, except from employees to the extent
required under existing contracts.

H.      Other Provisions.

        1. Definitions. As used herein, the following terms shall have the
following meanings:

            (a) "Collateral" means the property described on Exhibit D attached
hereto.

            (b) "Copyrights" means any and all copyright rights, copyright
applications, copyright registrations and like protections in each work or
authorship and derivative work thereof, whether published or unpublished and
whether or not the same also constitutes a trade secret, now or hereafter
existing, created, acquired or held.

            (c) "Intellectual Property Collateral" means:

                (i) Copyrights, Trademarks and Patents;

                (ii) Any and all trade secrets, and any and all intellectual
property rights in computer software and computer software products now or
hereafter existing, created, acquired or held;

                (iii) Any and all design rights which may be available to
Borrower now or hereafter existing, created, acquired or held;

                                      -11-
<PAGE>

                (iv) Any and all claims for damages by way of past, present and
future infringement of any of the rights included above, with the right, but not
the obligation, to sue for and collect such damages for said use or infringement
of the intellectual property rights identified above;

                (v) All licenses or other rights to use any of the Copyrights,
Patents or Trademarks, and all license fees and royalties arising from such use
to the extent permitted by such license or rights;

                (vi) All amendments, renewals and extensions of any of the
Copyrights, Trademarks or Patents; and

                (vii) All proceeds and products of the foregoing, including
without limitation all payments under insurance or any indemnity or warranty
payable in respect of any of the foregoing.

            (d) "Lien" means any lien (statutory or other), mortgage, pledge,
hypothecation, assignment, deposit arrangement, security interest, charge, claim
or other encumbrance of any kind (including any conditional sale or other title
retention agreement, any lease in the nature thereof, and any agreement to give
any security interest) and any agreement to give or refrain from giving a lien,
mortgage, pledge, hypothecation, assignment, deposit arrangement, security
interest, charge, claim or other encumbrance of any kind.

            (e) "Patents" means all patents, patent applications and like
protections including without limitation improvements, divisions, continuations,
renewals, reissues, extensions and continuations in part of the same.

            (f) "Permitted Liens" means: (i) Liens imposed by law, such as
carriers', warehousemen's, materialmen's and mechanics' liens, or Liens arising
out of judgments or awards against Borrower with respect to which Borrower at
the time shall currently be prosecuting an appeal or proceedings for review;
(ii) Liens for taxes not yet subject to penalties for nonpayment and Liens for
taxes the payment of which is being contested in good faith and by appropriate
proceedings and for which, to the extent required by generally accepted
accounting principles then in effect, proper and adequate book reserves relating
thereto are established by Borrower; (iii) purchase money security interests and
Liens in connection with capital leases incurred in the ordinary course of
business (to the extent such Liens are only on the leased property) or existing
on after acquired property at the time of its acquisition by the Borrower; (iv)
the Liens set forth on Schedule 2 hereto; and (v) leases and sublicenses of (but
not security interests in) Borrower's property granted to others in the ordinary
course of business.

            (g) "Trademarks" means any trademark and servicemark rights, whether
registered or not, applications to register and registrations of the same and
like protections, and the entire goodwill of the business of Borrower connected
with and symbolized by such trademarks.

            (h) "UCC" means the Uniform Commercial Code in effect from time to
time in the relevant jurisdiction.

                                      -12-
<PAGE>

        2. Governing Law; Venue. This Note shall be governed by the laws of the
State of California, without giving effect to conflicts of law principles.
Borrower and the Investors agree that all actions or proceedings arising in
connection with this Note shall be tried and litigated only in the state and
federal courts located in the City and County of Santa Clara, State of
California or, at the Investors' option, any court in which the Investors
determine it is necessary or appropriate to initiate legal or equitable
proceedings in order to exercise, preserve, protect or defend any of its rights
and remedies under this Note or otherwise or to exercise, preserve, protect or
defend its Lien, and the priority thereof, against the Collateral, and which has
subject matter jurisdiction over the matter in controversy.

        3. Notices. Any notice or communication required or desired to be
served, given or delivered hereunder shall be in the form and manner specified
below, and shall be addressed to the party to be notified as follows:

               If to Meier:             Dieter Meier
                                        c/o Data Sound
                                        Wohllebgasse #6
                                        CH-8001 Zurich, Switzerland
                                                   or
                                        c/o Soundproof, Inc.
                                        5180 Linwood Drive
                                        Los Angeles, CA 90027

               If to Bosch:             Walter Bosch
                                        Fraumunsterstr. 9
                                        8001 Zurich, Switzerland

               With a copy to:          Epstein Becker & Green, P.C.
                                        250 Park Avenue
                                        New York, New York 10177
                                        Attention: Lowell Lifschultz, Esq.
                                        Fax: (212) 661-0989

               If to other Investors:   The address set forth on the counterpart
                                        signature page hereto.

               If to Borrower:          Euphonix, Inc.
                                        220 Portage Avenue
                                        Palo Alto, California  94306
                                        Attention: Jeffrey Chew
                                        Fax: (650) 846-1131

               With a copy to:          Wilson Sonsini Goodrich & Rosati,
                                        Professional Corporation
                                        650 Page Mill Road
                                        Palo Alto, California  94304-1050
                                        Attn: Page Mailliard, Esq.

                                      -13-
<PAGE>

                               Fax: (650) 493-6811

or to such other address as each party designates to the other by notice in the
manner herein prescribed. Notice shall be deemed given hereunder if (i)
delivered personally or otherwise actually received, (ii) sent by an
internationally recognized overnight delivery service or (iii) sent via telecopy
machine with a duplicate signed copy sent on the same day as provided in clause
(ii) above. Notice telecopied as provided in clause (iii) above shall be
effective upon receipt of such telecopy if the duplicate signed copy is sent on
the same date as such receipt pursuant to clause (ii) above. Notice given in any
other manner described in this section shall be effective upon receipt by the
addressee thereof; provided, however, that if any notice is tendered to an
addressee and delivery thereof is refused by such addressee, such notice shall
be effective upon such tender unless expressly set forth in such notice.

        4. Investors' Rights; Borrower Waivers. The Investors' acceptance of
partial or delinquent payment from Borrower hereunder, or the Investors' failure
to exercise any right hereunder, shall not constitute a waiver of any obligation
of Borrower hereunder, or any right of the Investors hereunder, and shall not
affect in any way the right to require full performance at any time thereafter.
Except as otherwise expressly provided herein, Borrower waives presentment,
diligence, demand of payment, notice, protest and all other demands and notices
in connection with the delivery, acceptance, performance, default or enforcement
of this Note. In any action on this Note, the Investors need not produce or file
the original of this Note, but need only file a photocopy of this Note certified
by the Investors to be a true and correct copy of this Note in all material
respects.

        5. Severability. Whenever possible each provision of this Note shall be
interpreted in such manner as to be effective and valid under applicable law,
but if any provision is prohibited by or invalid under applicable law, it shall
be ineffective to the extent of such prohibition or invalidity, without
invalidating the remainder of the provision or the remaining provisions of this
Note.

        6. Amendment Provisions. Except for changes to Exhibit A to reflect the
amount of each Advance and related items, this Note may not be amended or
modified, nor may any of its terms be waived, except by a written instrument
signed by Borrower and the Investors who have advanced a majority of the
outstanding principal amount of this Note; provided, however, that no such
amendment shall, without the consent of each Investor to be affected thereby:
(i) except as expressly provided herein, extend the Maturity Date, (ii) reduce
the principal amount of any Advance or the Maximum Principal Amount, (iii)
decrease any interest rate under this Note, (iv) change the currency in which
this Note is payable, (v) impair any rights of an Investor against Borrower upon
any Event of Default, (vi) modify any of the conversion features of this Note or
increase the Conversion Price or (vii) impair any Investor's blanket lien on
Borrower's assets.

        7. Binding Effect. This Note shall be binding upon, and shall inure to
the benefit of, Borrower and the Investors and their respective successors and
assigns; provided, however, that Borrower's rights and obligations shall not be
assigned or delegated without the Investors' prior written consent, given in
their sole discretion, and any purported assignment or delegation without such
consent shall be void.

                                      -14-
<PAGE>

        8. Headings. Section headings used in this Note have been set forth
herein for convenience of reference only. Unless the contrary is compelled by
the context, everything contained in each section hereof applies equally to this
entire Note.

        9. Counterparts. This Agreement may be executed in any number of
counterparts, each of which shall be enforceable against the parties actually
executing such counterparts, and all of which together shall constitute one
instrument.

        10. No Usury. This Note is subject to the express condition that at no
time shall the Borrower be obligated or required to pay interest hereunder at a
rate which could subject the Investors to either civil or criminal liability as
a result of being in excess of the maximum rate which the Borrower is permitted
by law to contract or agree to pay. If, by the terms of this Note, the Borrower
is at any time required or obligated to pay interest at a rate in excess of such
maximum rate, the rate of interest under this Note shall be deemed to be
immediately reduced to such maximum rate and interest payable hereunder shall be
computed at such maximum rate and the portion of all prior interest payments in
excess of such maximum rate shall be applied and shall be deemed to have been
payments in reduction of the principal balance of this Note.

        11. Attorneys' Fees. Should any litigation, enforcement or collection
action be commenced between any of the parties to this Note under or in
connection with this Note, the prevailing party in such litigation, enforcement
or collection action shall be entitled, in addition to such other relief as may
be granted, to a reasonable sum as and for its attorneys' fees in such
litigation, enforcement or collection action which shall be determined by the
court in such litigation, enforcement or collection action or in a separate
action brought for that purpose. The provisions of this section shall survive
the entry of any judgment or award and shall continue to apply with respect to
any action to collect or recover any such judgment or award.

        12. Intercreditor Agreement. This Note is subject to the terms and
conditions of an Intercreditor Agreement, dated of even date herewith (the
"Intercreditor Agreement"), among Borrower, the Investors and certain other
holders of Secured Promissory Notes issued by Borrower. In the event of any
conflict between the provisions of Section 1 of the Intercreditor Agreement and
any provision of this Note, the provision of such Section 1 shall govern and
control.

                [Remainder of the Page Intentionally Left Blank]

                                      -15-
<PAGE>
        IN WITNESS WHEREOF, the Borrower and each of the Investors has caused
this Note to be duly executed on the date first written above.

                                        EUPHONIX, INC.

                                        By:    /s/ Jeffrey Chew
                                               --------------------------------
                                        Name:  Jeffrey Chew
                                        Title: Chief Executive Officer

                                        INVESTORS

                                        /s/ Dieter Meier
                                        ---------------------------------------
                                        Dieter Meier

                                        /s/ Walter Bosch
                                        ---------------------------------------
                                        Walter Bosch

                  [SIGNATURE PAGE TO SECURED PROMISSORY NOTE]

<PAGE>

                                   SCHEDULE 1

        IN WITNESS WHEREOF, the undersigned individual or entity hereby agrees
to make Advances (as defined in the Secured Promissory Note, dated November 29,
2001, (the "Note")), to which this signature page is appended, up to a maximum
of $________, and further agrees that this signature page shall constitute a
counterpart signature page to the Note, as a result of which the undersigned
shall be a party to the Note and an Investor (as defined therein) thereunder,
with all of the rights and obligations of an Investor set forth therein,
including the obligation to advance the undersigned's pro rata portion of any
Advance requested by the Borrower within three (3) business days of the date of
the request.

                                        INVESTOR

                                        Name:
                                                  ------------------------------

                                        Signature:
                                                  ------------------------------

                                        Date:
                                                  ------------------------------

                                        Amount:
                                                  ------------------------------

                                        Address:
                                                  ------------------------------

            [COUNTERPART SIGNATURE PAGE TO SECURED PROMISSORY NOTE]

<PAGE>

                                   SCHEDULE 2

                                 EXISTING LIENS

        1.  Secured Promissory Note, dated February 22, 2000, by and between
            Euphonix, Inc. and Dieter Meier, Walter Bosch, Milton Chang, Stephen
            D. Jackson, ONSET Enterprise Associates, L.P. and ONSET Enterprise
            Associates III, L.P.

        2.  Secured Promissory Note, dated April 14, 2000, by and between
            Euphonix, Inc. and Dieter Meier, Walter Bosch, ONSET Enterprise
            Associates, L.P. and ONSET Enterprise Associates III, L.P.

        3.  Secured Promissory Note, dated September 7, 2000, by and between
            Euphonix, Inc. and Walter Bosch.

        4.  Secured Promissory Note, dated December 29, 2000, by and between
            Euphonix, Inc. and Dieter Meier, Walter Bosch, ONSET Enterprise
            Associates, L.P., ONSET Enterprise Associates III, L.P. and the
            Jackson Trust dated 5/31/2000.

        5.  Secured Promissory Note, dated March 15, 2001, by and between
            Euphonix, Inc. and Dieter Meier and Walter Bosch.

<PAGE>

                                    EXHIBIT A

                              SCHEDULE OF ADVANCES

        The information set forth on this Exhibit A to the Secured Promissory
Note, dated November 29, 2001, shall be amended to reflect all Advances made to
Borrower hereunder.

<TABLE>
<CAPTION>
                                                                 AGGREGATE PRO
 NAME OF                                                         RATA SHARE OF         CONVERSION
 INVESTOR           DATE OF ADVANCE       AMOUNT OF ADVANCE       ALL ADVANCES            PRICE
 --------           ---------------       -----------------      -------------         ----------
<S>                <C>                    <C>                    <C>                   <C>
Walter Bosch       November 29, 2001           $150,000
Dieter Meier       November 29, 2001           $850,000

Totals:            At November 29, 2001       $1,000,000
</TABLE>

                                      -2-
<PAGE>

                                    EXHIBIT B

                          FORM OF COMMON STOCK WARRANT

<PAGE>

                                    EXHIBIT C

                            FORM OF VOTING AGREEMENT

<PAGE>

                                    EXHIBIT D

                        COLLATERAL DESCRIPTION ATTACHMENT
                           TO SECURED PROMISSORY NOTE

        All personal property of Borrower (herein referred to as "Borrower" or
"Debtor") whether presently existing or hereafter created, written, produced or
acquired, including, but not limited to:

        (1) all accounts receivable, accounts, chattel paper, contract rights
(including, without limitation, royalty agreements, license agreements and
distribution agreements), documents, instruments, money, deposit accounts and
general intangibles, including, without limitation, returns, repossessions,
books and records relating thereto, and equipment containing said books and
records, all investment property, including securities and securities
entitlements;

        (2) all software, computer source codes and other computer programs
(collectively, the "Software Products"), and all common law and statutory
copyrights and copyright registrations, applications for registration, now
existing or hereafter arising, United States of America and foreign, obtained or
to be obtained on or in connection with the Software Products, or any parts
thereof or any underlying or component elements of the Software Products
together with the right to copyright and all rights to renew or extend such
copyrights and the right (but not the obligation) of the Investors to sue in
their own name and/or the name of the Debtor for past, present and future
infringements of copyright;

        (3) all goods, including, without limitation, equipment and inventory
(including, without limitation, all export inventory);

        (4) all guarantees and other security therefor;

        (5) all trademarks, service marks, trade names and service names and the
goodwill associated therewith including, without limitation, the following:

                      Reel Feel(TM)
                      Clear Displays(TM)
                      Track Panner(TM)
                      SnapShot Recall(TM)
                      DSC(TM) (Digital Studio Controller)
                      Hyper-Surround(TM)
                      Total Automation(TM)
                      Mixview(TM)

        (6) (a) all patents and patent applications filed in the United States
Patent and Trademark Office or any similar office of any foreign jurisdiction,
and interests under patent license agreements, including, without limitation,
the inventions and improvements described and claimed therein, (including,
without limitation, United States Patents Nos. 5524060, 5402501, 5399820,
5677959 and

<PAGE>

6,057,829 and applications for United States patents for (i) Multiple Driver
Rotary Control for Audio Processors or Other Uses, (ii) Functional Panel for
Audio Mixer, and (iii) Plug-in Modules for Digital Signal Processor
Functionalities), (b) licenses pertaining to any patent whether Debtor is
licensor or licensee, (c) all income, royalties, damages, payments, accounts and
accounts receivable now or hereafter due and/or payable under and with respect
thereto, including, without limitation, damages and payments for past, present
or future infringements thereof, (d) the right (but not the obligation) to sue
for past, present and future infringements thereof, (e) all rights corresponding
thereto throughout the world in all jurisdictions in which such patents have
been issued or applied for, and (f) the reissues, divisions, continuations,
renewals, extensions and continuations-in-part with any of the foregoing (all of
the foregoing patents and applications and interests under patent license
agreements, together with the items described in clauses (a) through (f) in this
paragraph are sometimes herein individually and collectively referred to as the
"Patents");

        (7) all rights in and to (i) the on-air mixing consoles of the Series
CS3000B, (ii) mixer hardware software designs, (iii) Real Time(TM) software
design, and (iv) analog and digital audio hardware design expertise; and

        (8) all products and proceeds, including, without limitation, insurance
proceeds, of any of the foregoing.

Notwithstanding the foregoing, the grant of a security interest as provided
herein shall not extend to, and the term "Collateral" shall not include, any
contractual, license or lease rights or interests in which Borrower is the
grantee, licensee or lessee thereunder to the extent that Borrower, whether by
law or by the terms of such contract, license or lease, is not permitted to
assign or grant a security in interest in its rights thereunder without the
consent of the other party thereto.

                                      -2-<PAGE>
                                                                    EXHIBIT 4.2

        THE SECURITIES REPRESENTED HEREBY HAVE BEEN ACQUIRED FOR INVESTMENT AND
HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED. SUCH
SECURITIES MAY NOT BE SOLD OR TRANSFERRED IN THE ABSENCE OF SUCH REGISTRATION
UNLESS THE COMPANY RECEIVES AN OPINION OF COUNSEL REASONABLY ACCEPTABLE TO IT
STATING THAT SUCH SALE OR TRANSFER IS EXEMPT FROM THE REGISTRATION AND
PROSPECTUS DELIVERY REQUIREMENTS OF SUCH ACT.

        THE SECURITIES REPRESENTED BY THIS CERTIFICATE ARE SUBJECT TO CERTAIN
RESTRICTIONS UPON TRANSFER AND MAY BE TRANSFERRED ONLY IN ACCORDANCE WITH THE
TERMS OF AN AGREEMENT BETWEEN THE COMPANY AND THE REGISTERED HOLDER, A COPY OF
WHICH IS ON FILE AT THE PRINCIPAL OFFICE OF THE COMPANY.

                              COMMON STOCK WARRANT

                                       OF

                                 EUPHONIX, INC.

        This Warrant is being issued pursuant to that certain Secured Promissory
Note, dated ________, 200_ (the "Note"), by and between Euphonix, Inc., a
California corporation (the "Company"), and the Investors (as defined therein).

        This certifies that, for value received, ________ (the "Warrantholder")
is entitled, on the terms and subject to conditions set forth below, to
subscribe for and purchase from the Company at the Warrant Price defined in
Section 2 below, _____________ shares of fully paid and non-assessable shares of
the Company's Common Stock (the "Warrant Shares"). Such Warrant Price and such
number of Warrant Shares shall be subject to adjustment upon occurrence of the
contingencies set forth in this Warrant.

        Upon delivery of this Warrant (with the Notice of Exercise in the form
attached as Attachment A), together with payment of the Warrant Price for the
Warrant Shares thereby purchased, which payment may be made by converting this
Warrant or any portion thereof pursuant to Section 3 below ("Warrant
Conversion"), at the principal office of the Company or at such other office or
agency as the Company may designate by notice in writing to the holders hereof,
the holder of this Warrant shall be entitled to receive a certificate or
certificates for the Warrant Shares so purchased. All Warrant Shares which may
be issued upon the exercise of this Warrant will, upon issuance, be fully paid
and non-assessable and free from all taxes, liens and charges with respect
thereto.

        This Warrant is subject to the following terms and conditions:

<PAGE>

        1. Term of Warrant. This Warrant may be exercised in whole or in part,
at any time after such time as the Company has obtained shareholder approval of
an amendment to the Company's Articles of Incorporation to authorize a
sufficient number of additional shares of Common Stock for potential issuance
upon exercise of this Warrant, and prior to the earlier to occur of (i) 5:00
p.m., Pacific time, on the five-year anniversary of the date of this Warrant,
and (ii) five business days prior to the estimated closing date of an
Acquisition (as defined below) (the "Term"); provided, however, that in the
event this Warrant is exercised, in whole or in part, in connection with an
Acquisition, such exercise by the Warrantholder may be conditioned upon the
consummation of the Acquisition if so indicated by the Warrantholder pursuant to
the Notice of Exercise. For purposes of this Warrant, "Acquisition" shall mean a
sale of substantially all of the assets of the Company, or a merger or
consolidation of the Company with or into another corporation or entity,
pursuant to which the stockholders immediately prior to such merger or
consolidation hold less than 50% of the voting equity securities of the
surviving or acquiring entity immediately following such merger or
consolidation. Upon the expiration of the Term, this Warrant, to the extent not
exercised, shall terminate.

        2. Warrant Price. The exercise price of this Warrant (the "Warrant
Price") shall equal $0.01.

        3. Method of Exercise.

            (a) Cash Exercise. The purchase rights represented by this Warrant
may be exercised by the Warrantholder, in whole or in part, by the surrender of
this Warrant (with the duly executed Notice of Exercise attached as Attachment
A) at the principal office of the Company, and by the payment to the Company, by
certified or cashier's check, wire transfer or other acceptable means to the
Company, of an amount equal to the aggregate Warrant Price of the Warrant Shares
being purchased.

            (b) Net Issue Exercise. In lieu of exercising this Warrant for cash
under Section 3(a) above, the Warrantholder may elect to receive Warrant Shares
equal to the value of this Warrant (or the portion thereof being cancelled) by
surrender of this Warrant at the principal office of the Company and
specification of such election on the Notice of Election, in which event the
Company shall issue to the Warrantholder a number of Warrant Shares computed
using the following formula:

        X = Y(A-B)
            -------
               A

        Where  X      =      the number of Warrant Shares to be issued to the
                             Warrantholder.

               Y      =      the number of Warrant Shares for which this Warrant
                             is then being exercised.

               A      =      the fair market value of one share of the Company's
                             Common Stock.

               B      =      the Warrant Price (as adjusted to the date of such
                             calculation).

                                      -2-
<PAGE>

        For purposes of this Section 3(b), the fair market value of the
Company's Common Stock shall mean the average closing price of the Company's
Common Stock quoted on the Nasdaq National Market, Nasdaq Small Cap Market or
Over-the-Counter Bulletin Board Market, or the closing prices quoted on any
exchange on which the Common Stock is listed, whichever is applicable, as
published in the Western Edition of The Wall Street Journal for the five trading
days prior to the date of determination of fair market value.

        4. Adjustment of Warrant Price and Number of Warrant Shares. The number
and kind of Warrant Shares purchasable upon the exercise of this Warrant and the
Warrant Price shall be subject to adjustment from time to time in accordance
with the following provisions:

            (a) Reclassification or Consolidation. In case of any
reclassification, consolidation or change of outstanding securities of the class
issuable upon exercise of this Warrant (other than as a result of a subdivision
or combination), the Company shall execute a new Warrant, providing that the
holder of this Warrant shall have the right to exercise such new Warrant, and
procure upon such exercise in lieu of each Warrant Share previously issuable
upon exercise of this Warrant, the kind and amount of shares of stock, other
securities, money and property receivable upon such reclassification or change
by a holder of one Warrant Share. Such new Warrant shall provide for adjustments
which shall be as nearly equivalent as may be practicable to the adjustments
provided for in this Section 4. The provisions of this Section 4(a) shall
similarly apply to successive reclassifications, consolidations or changes.

            (b) Subdivision or Combination of Shares. If the Company at any time
while this Warrant remains outstanding and unexpired shall subdivide or combine
its Common Stock, the Warrant Price shall be proportionately decreased in the
case of a sub-division or increased in the case of a combination.

            (c) Adjustment of Number of Shares. Upon each adjustment in the
Warrant Price as contemplated under Section 4(b) above, the number of Warrant
Shares purchasable hereunder shall be adjusted, to the nearest whole share, to
the product obtained by multiplying the number of shares purchasable immediately
prior to such adjustment in the Warrant Price by a fraction, the numerator of
which shall be the Warrant Price immediately prior to such adjustment and the
denominator of which shall be the Warrant Price immediately thereafter.

        5. Notices. Upon (i) any adjustment of the Warrant Price and any
increase or decrease in the Warrant Shares purchasable upon the exercise of this
Warrant, or (ii) a proposed Acquisition, the Company shall give written notice
of such adjustment and increase/decrease promptly thereafter, or, in the event
of an Acquisition, at least ten business days prior to the estimated closing
date of the Acquisition, to the registered holder of this Warrant (a "Notice").
The Notice shall be mailed to the address of such holder as shown on the books
of the Company and shall state (i) the Warrant Price as adjusted and/or the
increased or decreased number of Warrant Shares purchasable upon the exercise of
this Warrant, setting forth in reasonable detail the method of calculation of
each, or (ii) the terms and estimated timing of the proposed Acquisition, as the
case may be.

        6. Miscellaneous.

                                      -3-
<PAGE>

            (a) The terms of this Warrant shall be binding upon and shall inure
to the benefit of any successors or assigns of the Company and of any permitted
assigns of the Warrantholder. Neither this Warrant nor any right or obligation
hereunder may be transferred by the Warrantholder without the express written
consent of the Company.

            (b) No holder of this Warrant, as such, shall be entitled to vote or
receive dividends or be deemed to be a stockholder of the Company for any
purpose, nor shall anything contained in this Warrant be construed to confer
upon the holder of this Warrant, as such, any rights of a stockholder of the
Company or any right to vote, give or withhold consent to any corporate action,
receive notice of meetings or receive dividends, or otherwise.

            (c) Receipt of this Warrant by the holder hereof shall constitute
acceptance of and agreement to the foregoing terms and conditions.

            (d) Upon receipt of evidence reasonably satisfactory to the Company
of the loss, theft, destruction or mutilation of this Warrant and, in the case
of any such loss, theft or distribution, upon delivery of an indemnity agreement
reasonably satisfactory in form and amount to the Company or, in the case of any
such mutilation, upon surrender and cancellation of such Warrant, the Company at
its expense will execute and deliver, in lieu thereof, a new Warrant of like
date and tenor.

            (e) Any provision of this Warrant may be amended, waived or modified
upon the written consent of both the Company and the Warrantholder; provided,
however, that the holders of the Warrants issued pursuant to the Note and
Warrant Purchase Agreement dated November 29, 2001 representing a majority of
the Warrant Shares issued or issuable upon exercise of such Warrants may amend,
waive or modify any provision of the Warrants on behalf of all holders of the
Warrants (including the Warrantholder).

            (f) This Warrant shall be governed by the internal substantive laws,
but not the choice of law rules, of the State of California.

                [remainder of the page intentionally left blank]

                                      -4-
<PAGE>

        IN WITNESS WHEREOF, the Company has caused this Warrant to be signed by
its duly authorized officer.

        Dated: _________, 200_

                                        EUPHONIX, INC.

                                        By:___________________________________
                                           Jeffrey Chew, Chief Executive Officer

                                      -5-
<PAGE>

                                  ATTACHMENT A

                               NOTICE OF EXERCISE

TO:     Euphonix, Inc.
        220 Portage Avenue
        Palo Alto, CA  94306
        Attn:  Chief Executive Officer

        1. The undersigned hereby elects to purchase ___________ shares of the
Common Stock of Euphonix, Inc. (the "Shares") pursuant to the terms of the
attached Warrant, and tenders herewith payment of the purchase price of such
shares in full, together with all applicable transfer taxes, if any.

        2. The undersigned hereby elects to exercise the purchase right with
respect to ______% of such shares of such Common Stock through Warrant
Conversion, as set forth in Section 3(b) of the attached Warrant.

        3. Please issue a certificate(s) representing such shares of Common
Stock in the name of the undersigned or in such other name as is specified
below:

        ---------------------------------
        (Name)

        ---------------------------------

        ---------------------------------
        (Address)

        4. If the attached Warrant is being exercised in connection with an
Acquisition, the undersigned hereby notifies Euphonix, Inc., by indicating
below, that its exercise hereunder is conditioned upon the consummation of the
Acquisition and, in the event the consummation of the Acquisition does not
occur, this Notice of Exercise shall be canceled and deemed null and void.

               __________ The undersigned hereby states that its exercise of the
               attached Warrant is conditioned upon the consummation of the
               Acquisition and, in the event the consummation of the Acquisition
               does not occur, this Notice of Exercise shall be canceled and
               deemed null and void.

        5. If the undersigned is electing to purchase the Shares prior to such
Shares being registered under the Securities Act of 1933, as amended (the
"Securities Act"), the undersigned represents that the Shares of Common Stock
are being acquired for the account of the undersigned for investment and not
with a view to, or for resale in connection with, the distribution thereof and
that the undersigned has no present intention of distributing or reselling such
Shares. In support thereof, the undersigned will execute the Investment
Representation Statement attached as Exhibit A. In the event the undersigned is
electing to purchase the Shares after such Shares have

                                      -6-
<PAGE>

been registered under the Securities Act pursuant to a registration statement
declared effective by the Securities and Exchange Commission, the undersigned
will execute a modified Investment Representation Statement reasonably
satisfactory to the Company.

                                        Signature of Warrantholder

                                        ----------------------------------------

                                        By:
                                            ------------------------------------

                                        Title:
                                               ---------------------------------

                                        Date:
                                              ----------------------------------

                                      -7-
<PAGE>

                                    EXHIBIT A

        THIS STATEMENT MUST BE COMPLETED, SIGNED AND RETURNED TO EUPHONIX, INC.
ALONG WITH THE NOTICE OF EXERCISE BEFORE THE COMMON STOCK ISSUABLE UPON EXERCISE
OF THE ATTACHED WARRANT WILL BE ISSUED.

                                 EUPHONIX, INC.

                                WARRANT EXERCISE

                       INVESTMENT REPRESENTATION STATEMENT

PURCHASER:  ______________________

COMPANY:  Euphonix, Inc.

SECURITY:  Common Stock

NUMBER OF SHARES:  _______________

DATE :_______________, 200__

        In connection with the purchase of the above-listed Securities, the
Purchaser represents to the Company the following:

        (a) It has substantial experience in evaluating and investing in private
placement transactions of securities in companies similar to the Company so that
it is capable of evaluating the merits and risks of its investment in the
Company and has the capacity to protect its own interests. It acknowledges that
its investment in the Company is highly speculative and entails a substantial
degree of risk and it is in a position to lose the entire amount of such
investment.

        (b) It is acquiring the Securities for investment for its own account,
not as a nominee or agent, and not with the view to, or for resale in connection
with, any distribution thereof. It understands that the Securities have not been
registered under the Securities Act of 1933, as amended (the "Securities Act"),
but instead are issued pursuant to a specific exemption from the registration
provisions of the Securities Act, the availability of which depends upon, among
other things, the bona fide nature of the investment intent and the accuracy of
its representations as expressed herein. It is an "accredited investor" within
the meaning of Regulation D, Rule 501(a), promulgated by the Securities and
Exchange Commission.

        (c) It acknowledges that the Securities must be held indefinitely unless
subsequently registered under the Securities Act or unless an exemption from
such registration is available. It is aware of the provisions of Rule 144
promulgated under the Securities Act which permit limited resale of shares
purchased in a private placement subject to the satisfaction of certain
conditions, including, among other things, the existence of a public market for
the shares, the availability of

                                      -8-
<PAGE>

certain current public information about the Company, the resale occurring not
less than one year after a party has purchased and paid for the security to be
sold, the sale being effected through a "broker's transaction" or in
transactions directly with a "market maker" and the number of shares being sold
during any three-month period not exceeding specified limitations.

        (d) It understands that no public market may exist for any of the
Securities and that the Company has made no assurances that a public market may
exist for the Securities.

        (e) It has had an opportunity to discuss the Company's business,
management and financial affairs with its management. It has also had an
opportunity to ask questions of officers of the Company, which questions were
answered to its satisfaction. It understands that such discussions, as well as
any written information issued by the Company, were intended to describe certain
aspects of the Company's business and prospects but were not a thorough or
exhaustive description. It acknowledges that any business plans prepared by the
Company have been and continue to be subject to change and that such business
plans are necessary speculative in nature, and it can be expected that some or
all of the assumptions used in such plans may not materialize or may vary
significantly from actual results.

        (f) It understands that the certificates evidencing the Securities may
be imprinted with legend(s) which prohibit the transfer of the Securities unless
they are registered or such registration is not required in the opinion of
counsel for the Purchaser, reasonably satisfactory to the Company, or unless the
Company receives a no-action letter from the SEC.

        The following legends may be placed on the certificate(s) for the
Securities, or any substitutions therefor:

        THE SECURITIES REPRESENTED BY THIS CERTIFICATE HAVE BEEN ACQUIRED FOR
        INVESTMENT AND HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF
        1933, AS AMENDED. SUCH SECURITIES MAY NOT BE SOLD OR TRANSFERRED IN THE
        ABSENCE OF SUCH REGISTRATION UNLESS THE COMPANY RECEIVES AN OPINION OF
        COUNSEL REASONABLY ACCEPTABLE TO IT STATING THAT SUCH SALE OR TRANSFER
        IS EXEMPT FROM THE REGISTRATION AND PROSPECTUS DELIVERY REQUIREMENTS OF
        SUCH ACT.

        THE SECURITIES REPRESENTED BY THIS CERTIFICATE ARE SUBJECT TO CERTAIN
        RESTRICTIONS UPON TRANSFER AND MAY BE TRANSFERRED ONLY IN ACCORDANCE
        WITH THE TERMS OF AN AGREEMENT BETWEEN THE COMPANY AND THE REGISTERED
        HOLDER, A COPY OF WHICH IS ON FILE AT THE PRINCIPAL OFFICE OF THE
        COMPANY.

        (g) In connection with any public offering of the Company's securities,
it agrees, upon request of the Company or the underwriters managing any
underwritten offering of the Company's securities, not to sell, make any short
sale of, loan, grant any option for the purchase of, or otherwise dispose of any
of the Securities (other than those included in the registration) without the
prior written consent of the Company or such underwriters, as the case may be,
for such period of time

                                      -9-
<PAGE>

(not to exceed 90 days) from the effective date of such registration as may be
requested by the underwriters.

                                        Signature of Purchaser:

                                        By:
                                            ------------------------------------

                                        Title:
                                               ---------------------------------

                                        Date:
                                              ----------------------------------

                                      -10-

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00032-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00032-of-00352.parquet"}]]